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After publication of the original article \[[@CR1]\], we were notified that columns in Table 2 were erroneously displayed.

The correction version of Table [2](#Tab1){ref-type="table"} is shown below. Table 2Characteristics of cohort of *BRCA1* and *BRCA2* mutation carriers*BRCA1* mutation carriers*BRCA2* mutation carriersUnaffected women (*N* = 2003)Women with breast cancer (*N* = 269)Unaffected women (*N* = 1448)Women with breast cancer (*N* = 157)Total Person-years of follow-up11,20711347286600Person-years of follow-up (mean (sd))5.60 (3.67)4.21 (3.27)5.03 (3.44)3.82 (3.08)Age at start of follow-up (mean (sd))37.51 (11.80)40.68 (10.25)40.00 (12.53)45.14 (10.11)Age at diagnosis/censoring (mean (sd))43.10 (12.28)44.90 (10.33)45.00 (13.00)48.97 (10.30)Reason for censoring Breast cancer02690157 Ovarian cancer493^*a*^91^a^ Other cancer455^*a*^282^a^ RRM299--181-- Death5--8-- Unaffected at last follow-up time1605--1222--Year of birth \< =1960604 (83.54)119 (16.46)500 (84.75)90 (15.25) \> 19601399 (90.32)150 (9.68)948 (93.40)67 (6.60)Menopausal status Premenopausal at censoring^*b*^  Last information^c^ after censoring5126934435  Last information before censoring^*d*^5855847335 Postmenopausal  Natural menopause age known1942718231  Natural menopause age unknown5071 Post hysterectomy70126411  Unknown menopausal status6213338RRSO status at censoring No RRSO  Last information after censoring66411046779  Last information before censoring6184453527 RRSO72111544651  As reason for menopause^*e*^5749034536  After natural menopause101187610  After hysterectomy467255*Abbreviations*: *RRSO* Risk-Reducing Salpingo-oophorectomy, *RRM* Risk Reducing Mastectomy^*a*^Diagnosed at the same time as breast cancer^*b*^Fifteen women did not report age at menopause but were older than 60 years at the end of follow-up^*c*^Information from questionnaire and record linkage^*d*^Age last known to be premenopausal: mean 32.3 years, median 31 years for *BRCA1* mutation carriers: mean 33.9, median 34 years for *BRCA2* mutation carriers. Time between this age and end of censoring: mean 6.3, median 5 years for *BRCA1* and mean 6 years, median 5 years for *BRCA2* mutation carriers^*e*^Seven women reported RRSO after age 60 years without first reporting natural menopause
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